HK1128871A1 - 用於草酸鹽還原菌的藥物組合物 - Google Patents

用於草酸鹽還原菌的藥物組合物

Info

Publication number
HK1128871A1
HK1128871A1 HK09102055.9A HK09102055A HK1128871A1 HK 1128871 A1 HK1128871 A1 HK 1128871A1 HK 09102055 A HK09102055 A HK 09102055A HK 1128871 A1 HK1128871 A1 HK 1128871A1
Authority
HK
Hong Kong
Prior art keywords
oxalate
pharmaceutical compositions
reducing bacteria
bacteria
reducing
Prior art date
Application number
HK09102055.9A
Other languages
English (en)
Inventor
Poonam Kaul
Harmeet Sidhu
Original Assignee
Oxthera Intellectual Property Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxthera Intellectual Property Ab filed Critical Oxthera Intellectual Property Ab
Publication of HK1128871A1 publication Critical patent/HK1128871A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
HK09102055.9A 2005-12-14 2009-03-03 用於草酸鹽還原菌的藥物組合物 HK1128871A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/045457 WO2007070052A2 (en) 2005-12-14 2005-12-14 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease

Publications (1)

Publication Number Publication Date
HK1128871A1 true HK1128871A1 (zh) 2009-11-13

Family

ID=36581703

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09102055.9A HK1128871A1 (zh) 2005-12-14 2009-03-03 用於草酸鹽還原菌的藥物組合物

Country Status (15)

Country Link
US (2) US20100028422A1 (zh)
EP (2) EP1962873B1 (zh)
JP (2) JP5047190B2 (zh)
AU (2) AU2005339139A1 (zh)
CA (2) CA2645871A1 (zh)
CY (2) CY1114397T1 (zh)
DK (1) DK1962873T3 (zh)
ES (2) ES2426258T3 (zh)
HK (1) HK1128871A1 (zh)
HU (1) HUE034539T2 (zh)
LT (1) LT1965816T (zh)
PL (2) PL1962873T3 (zh)
PT (1) PT1962873E (zh)
SI (1) SI1962873T1 (zh)
WO (2) WO2007070052A2 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
EP1962873B1 (en) * 2005-12-14 2013-05-29 OxThera, Inc., Pharmaceutical compositions comprising oxalate-reducing bacteria
CN104013581A (zh) * 2005-12-16 2014-09-03 奥克斯赛拉公司 用于减少草酸和/或其盐的组合物和方法
CN103272225B (zh) 2006-08-02 2018-05-22 味之素阿尔西亚有限公司 结晶化的草酸脱羧酶和使用方法
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
JP5632289B2 (ja) * 2008-09-30 2014-11-26 株式会社明治 高いシュウ酸分解能を有する乳酸菌
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
US8431122B2 (en) * 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
PL2449098T3 (pl) * 2009-07-02 2017-06-30 Oxthera Intellectual Property Ab Oczyszczanie i izolacja rekombinowanych enzymów rozkładających szczawian i cząstki suszone rozpryskowo zawierające enzymy rozkładające szczawian
EP2270138B1 (en) 2009-07-02 2018-03-28 OxThera Intellectual Property AB Purification and isolation of recombinant oxalate degrading enzymes
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
CN102725403A (zh) * 2009-11-25 2012-10-10 凯普托杰姆有限责任公司 草酸相关疾病治疗方法和组合物
HK1253538A1 (zh) * 2010-08-04 2019-06-21 Borody Thomas J 用於糞便菌群植入的組合物及其製備和使用方法
SG187713A1 (en) * 2010-08-04 2013-03-28 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
US20140112985A1 (en) * 2012-10-22 2014-04-24 Polonez Therapeutics Llc Method of prevention and treatment of clostridium difficile infection
US9714456B2 (en) 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
CA2913476A1 (en) 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
WO2015002588A1 (en) 2013-07-05 2015-01-08 Oxthera Intellectual Property Ab Secretagogues derived from oxalobacter formigenes
WO2015097148A1 (en) * 2013-12-23 2015-07-02 Nexttobe Ab Method for producing oxalate oxidases having activity optimum near physiological ph and use of such recombinant oxalate oxidases in the treatment of oxalate-related diseases
US10799541B2 (en) 2014-07-01 2020-10-13 Probi USA, Inc. Bi-layer dual release probiotic tablets
US11603524B2 (en) 2015-04-02 2023-03-14 Oxidien Pharmaceuticals, Llc High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
FR3045384B1 (fr) * 2015-12-18 2020-02-07 Institut National De La Recherche Agronomique Composition lyophilisee pour la conservation de microbiote dans son ecosysteme
CN106974262B (zh) * 2016-01-15 2021-05-25 深圳华大生命科学研究院 肠道益生杆菌在治疗和预防肥胖及其相关疾病中的应用
CN109152796A (zh) * 2016-03-09 2019-01-04 因库博实验室有限责任公司 用于将活细胞递送至实体组织的方法和制品
AU2017286220A1 (en) * 2016-06-13 2018-12-06 Oxthera Intellectual Property Ab Compositions and methods for the treatment or prevention of oxalate-related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
KR20200088394A (ko) 2017-11-17 2020-07-22 에보니크 오퍼레이션즈 게엠베하 코팅된 경질 셸 캡슐의 제조 방법
CN110734861B (zh) * 2018-07-20 2022-02-11 中国农业大学 一种猪肠道食糜微生物组的体外保藏方法
EP3860628A4 (en) * 2018-10-04 2022-08-17 OxThera Intellectual Property AB NEW MEDICAL USE OF OXALATE-REDUCING BACTERIA
EP3646857A1 (en) * 2018-11-01 2020-05-06 Evonik Operations GmbH Colonic delivery system for microorganisms
CN109402022A (zh) * 2018-12-05 2019-03-01 上海上药信谊药厂有限公司 一种产甲酸草酸杆菌及其应用
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3030185A1 (de) 1980-08-07 1982-04-08 Kohlbecker, Günther, 3000 Hannover Verfahren zur enzymatischen entfernung von oxalat mittels oxalat-oxidase
DE3204284A1 (de) 1982-02-06 1983-08-18 Kohlbecker, Günther, 3000 Hannover Verfahren zur enzymatischen entfernung von sauerstoff
JPS5968344A (ja) * 1982-10-12 1984-04-18 Agency Of Ind Science & Technol 非対称機能膜及びその製法
US4539118A (en) * 1984-03-23 1985-09-03 Sigma Chemical Company Rapid, accurate method of separation of oxalate from urine and other biological fluids
US5263992A (en) * 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
WO1994012622A1 (en) * 1992-11-30 1994-06-09 Zeneca Limited Oxalate decarboxylase
EP0693884A4 (en) * 1993-04-16 1996-03-27 Mccormick & Co Inc ENCLOSURE COMPOSITIONS
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5554147A (en) * 1994-02-01 1996-09-10 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5505713A (en) * 1994-04-01 1996-04-09 Minimed Inc. Indwelling catheter with stable enzyme coating
JPH10500019A (ja) 1994-05-18 1998-01-06 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ヒトのオキサリル−ＣｏＡデカルボキシラーゼ
US6214980B1 (en) * 1994-06-20 2001-04-10 University Of Florida Materials and methods for detection of Oxalobacte formigenes
US6090628A (en) 1994-06-20 2000-07-18 University Of Florida Materials and methods for detection of Oxalobactor formigenes
US5912125A (en) * 1994-06-20 1999-06-15 University Of Florida Materials and methods for detection of oxalobacter
US5604111A (en) 1994-06-20 1997-02-18 University Of Florida Research Foundation Method and kit for detection of oxalate
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
SE9603029D0 (sv) 1996-08-20 1996-08-20 Svenska Traeforskningsinst Method for lowering the level of oxalic acid
US6297425B1 (en) * 1997-03-21 2001-10-02 Pioneer Hi-Bred International, Inc. Gene encoding oxalate decarboxylase from aspergillus phoenices
KR20010012845A (ko) * 1997-05-23 2001-02-26 아익션 바이오테크놀로지, 인코퍼레이티드 옥살산염 관련 질병의 예방을 위한 옥살산염-분해 미생물또는 옥살산염-분해 효소
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US20040120941A1 (en) * 1997-05-23 2004-06-24 Allison Milton J. Materials and methods for treating or preventing oxalate-related disease
US6355242B1 (en) * 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US6161499A (en) * 1997-07-07 2000-12-19 Cvd Diamond Corporation Apparatus and method for nucleation and deposition of diamond using hot-filament DC plasma
US6080404A (en) * 1997-09-05 2000-06-27 University Of Florida Materials and methods for removal of substances from fluids
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) * 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
CN100358509C (zh) * 1998-09-28 2008-01-02 沃纳-兰伯特公司 采用hpmc胶囊进行肠和结肠传递
IT1309427B1 (it) 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
AU779427B2 (en) 1999-06-07 2005-01-27 Nanotherapeutics, Inc. Methods for coating particles and particles produced thereby
DE10026541A1 (de) * 2000-05-27 2001-11-29 Zeiss Carl Vorrichtung zur präzisen Positionierung eines Bauteils, insbesondere eines optischen Bauteiles
AU2001284427A1 (en) 2000-09-07 2002-03-22 Shingo Tomoda Analog electronic drum set, parts for drum stick, analog electronic drum set andfoot-pedal unit
CA2442602A1 (en) * 2000-12-18 2002-08-01 Probio Health, Llc Probiotic compounds derived from lactobacillus casei strain ke01
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
US6929940B1 (en) * 2002-08-20 2005-08-16 University Of Florida Research Foundation, Inc. Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
EP1962873B1 (en) * 2005-12-14 2013-05-29 OxThera, Inc., Pharmaceutical compositions comprising oxalate-reducing bacteria

Also Published As

Publication number Publication date
ES2426258T8 (es) 2014-11-06
CA2650122A1 (en) 2007-06-21
EP1962873B1 (en) 2013-05-29
PT1962873E (pt) 2013-08-29
US20100028422A1 (en) 2010-02-04
CA2650122C (en) 2015-05-12
CA2645871A1 (en) 2007-06-21
CY1118936T1 (el) 2018-01-10
US20070178070A1 (en) 2007-08-02
JP2009519333A (ja) 2009-05-14
JP5047190B2 (ja) 2012-10-10
SI1962873T1 (sl) 2013-10-30
CY1114397T1 (el) 2016-08-31
HUE034539T2 (en) 2018-02-28
EP1965816A4 (en) 2012-03-07
WO2007070052A2 (en) 2007-06-21
ES2628090T3 (es) 2017-08-01
WO2007070677A2 (en) 2007-06-21
WO2007070677A3 (en) 2008-11-20
EP1965816B1 (en) 2017-04-05
LT1965816T (lt) 2017-07-25
AU2006326016A1 (en) 2007-06-21
JP5203217B2 (ja) 2013-06-05
AU2006326016B2 (en) 2013-10-10
AU2005339139A8 (en) 2008-08-07
WO2007070052A3 (en) 2009-04-16
US8545836B2 (en) 2013-10-01
JP2009531275A (ja) 2009-09-03
DK1962873T3 (da) 2013-08-26
PL1962873T3 (pl) 2014-03-31
ES2426258T3 (es) 2013-10-22
EP1962873A2 (en) 2008-09-03
EP1965816A2 (en) 2008-09-10
AU2005339139A1 (en) 2007-06-21
PL1965816T3 (pl) 2017-08-31
EP1962873A4 (en) 2010-08-11

Similar Documents

Publication Publication Date Title
HK1244267A1 (zh) 包含(r)-n-甲基納曲酮的藥物組合物
PL1962873T3 (pl) Kompozycje farmaceutyczne zawierające bakterie zmniejszające ilość szczawianu
GB0513692D0 (en) Novel pharmaceutical compositions
IL223545A0 (en) Pharmaceutical compositions
EP1765283A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0408308D0 (en) Pharmaceutical compositions
IL188352A0 (en) Pharmaceutical compositions
IL186336A0 (en) Pharmaceutical composition
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
ZA200804103B (en) Pharmaceutical compositions
IL185197A0 (en) Ophthalmological pharmaceutical compositions
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
EP1862184A4 (en) PHARMACEUTICAL COMPOSITION
GB0522045D0 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
EP1845944A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA200803566B (en) Pharmaceutical compositions
GB0514259D0 (en) Pharmaceutical compositions
EP1747205A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0400971D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0515306D0 (en) Pharmaceutical compositions
GB0525269D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221208